Santa Fe Partners’s AstraZeneca AZN Stock Holding History

Santa Fe Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-30,477	Closed	-$2.09M	–	478
2015 Q1	$2.09M	Buy	+30,477	New	+$2.12M	0.25%	165
2014 Q2	–	Sell	-4,905	Closed	-$318K	–	490
2014 Q1	$318K	Buy	+4,905	New	+$317K	0.05%	408
2013 Q3	–	Sell	-21,507	Closed	-$1.02M	–	463
2013 Q2	$1.02M	Buy	+21,507	New	+$1.1M	0.21%	197

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Santa Fe Partners's AZN Position: Q2 2015 in Review

Santa Fe Partners sold out of AstraZeneca (AZN) in Q2 2015, closing a stake of 30,477 shares — an estimated $2.09M sold.

Santa Fe Partners first reported a position in AZN in Q2 2013 and held it in 3 quarters. The position peaked at $2.09M in Q1 2015. 376 funds tracked by Wall St. Rank hold AZN as of Q2 2015.

Santa Fe Partners reported no remaining AstraZeneca position as of Q2 2015 after selling out during the quarter.
Santa Fe Partners sold 30,477 AstraZeneca shares in Q2 2015, an estimated $2.09M.
Santa Fe Partners first reported a position in AstraZeneca in Q2 2013 and held it in 3 quarters.
Santa Fe Partners's AstraZeneca position peaked at $2.09M in Q1 2015.
376 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2015.

Based on Santa Fe Partners's 13F filing for Q2 2015, filed 13 Aug 2015.